ICHOM Australasian ForumCatalysing the Value Agenda

4 May 2017 | Shangri-La Hotel | Sydney, Australia

AgendaThursday 4 May 2017

Time Topic Speaker

08:00 - 08:30 Registration

08:35 - 08:45 Welcome to Country Uncle Ray Davison, Gadigal Elder

08:45 - 09:00 VBHC: An Idea Whose Time Has Come Elizabeth Koff

09:00 - 09:30 Defining Value: The Patient Perspective Julien Wiggins

09:30 - 10:00 ICHOM and The Strategy to Transform Health Care Globally Dr Christina Akerman

10:00 - 10:30 From Theory to Practice: The Value Framework in Action Dr Thomas Feeley

10:30 - 11:00 Morning Tea

11:00 - 11:30 Shared Value: System-Wide Collaboration & Measurement Dr Eric Hans Eddes

11:30 - 12:00 From Volume to Value: How Funders Are Driving the Value Agenda David Lansky, PhD

12:00 - 13:00 Networking Lunch

13:00 - 14:30 Breakout Session 1A Patient-Reported Outcomes: Measuring What Matters

1. Prof Madeleine King (University of Sydney)2. Prof Konrad Pesudovs (Flinders University)3. Melissa Tinsley (NSW Agency for Clinical

Innovation)

Breakout Session 1B Clinical Registries: System-Level Outcomes Measurement

1. Prof Christopher Reid (Curtin University) 2. Prof John Beltrame (University of Adelaide)

& Rosanna Tavella (University of Adelaide)3. A/Prof Sue Evans (Monash University)4. Dr Robert Herkes (ACSQHC)

14:30 - 14:45 Break

14:45 - 16:15 Breakout Session 2A Implementation: Putting Outcomes Measurement into Practice

1. Melanie Hay (Safer Care Victoria) 2. A/Prof Ilana Ackerman (Monash University)

& Bernarda Cavka (Royal Melbourne)3. Catriona Calvert (Pindara Private) &

Kylie Mills (Pindara Private)

Breakout Session 2B Technology and Infrastructure: Enabling Outcomes Measurement

1. Wim Smit (MRDM)2. Dr Femida Gwadry-Sridhar &

Ra’ad Siraj (Pulse Infoframe)3. Bryan Walther (Oberd)

16:15 - 16:45 Afternoon Tea

16:45- 17:15 Shaping the Agenda for Health Systems Transformation: The Global Perspective

Dr Stefan Larsson

17:15 - 17:30 Closing Remarks

17:30 - 19:00 Networking Reception

Sponsoring Partners

Supporting Partners

Elizabeth KoffElizabeth commenced her career as an allied health professional working in a range of clinical settings both in NSW and Victoria before undertaking further qualifications in public health and health policy.

Elizabeth has held a number of Senior Executive planning and operational roles

within the NSW health system, including Chief Executive of the Sydney Children’s Hospitals Network, Director, Clinical Operations, South Eastern Sydney Illawarra Area Health Service and Director, Population Health Planning and Performance, South Eastern Sydney Illawarra Area Health Service.

In February 2015, Elizabeth commenced in the role of Deputy Secretary, Strategy and Resources at the NSW Ministry of Health where she was responsible for strategic health policy development, inter-jurisdictional negotiations, system-wide planning of health services, and setting the strategic direction for whole of government responses to many intractable social problems.

In May 2016, Elizabeth was appointed Secretary, NSW Health. As Secretary, Elizabeth is committed to strategically re-shaping health services to provide better value care and improved patient outcomes, ensuring NSW continues to lead the nation in delivering high quality care to its communities.

Eric Hans Eddes, MD, PhDEric Hans Eddes MD, Phd, was educated as a medical doctor at the University of Groningen in the Netherlands. At the Leiden University Medical Centre he was trained as a general surgeon and differentiated as a GastroIntestinal Surgeon at the Groningen University Medical Centre. His PhD thesis “clinical

and pathofysiological aspects of chronic pancreatitis and duodenum preserving resection of the head of the pancreas” was performed during his surgical training. As a surgical resident and work as GastroIntestinal Surgeon he was always active in respectively professional boards. From this perspective he became engaged in quality, improvement and transparancy in health care and was one of the initiators implementing clinical auditing in the Netherlands. At this moment he is GastroIntesitinal Surgeon at the Deventer Hospital, a teaching hospital in the Netherlands and director of the Dutch Insitute for Clinical Auditing, an organization facilitating 23 clinical registries with a nationwide coverage in the Netherlands (www.dica.nl).

Julien WigginsAs the CEO of Australia’s leading bowel cancer organisation, Julien Wiggins draws on his economics, law and government background when addressing one of the most challenging problems facing Australia’s public health - bowel cancer.

Under his leadership of Bowel Cancer Australia, the 100% community-funded

charity realised its long-term goal of funding the $8.9 million Lawrence Penn Chair in Bowel Cancer Research at the University of Sydney.

Mr Wiggins also played an integral role in the formation of the charity’s Bowel Care Nurses and Nutritionist Services; Peer-to-Peer Support Network; pharmacy-based screening programs - BowelScreen Australia and BowelScreen Aotearoa (NZ); the creation of a world-first bowel cancer app; and the development of a global standard set of patient outcome measurements.

He led the call for the expansion of the National Screening Program to comply with medical guidelines; timely access to colonoscopy; and better availability to affordable treatments, including biomarker testing and precision medicine.

Mr Wiggins continues to work with national and international stakeholders on a range of campaigns covering bowel cancer prevention and screening, early detection and diagnosis, treatment, recovery, care and support.

Christina Rångemark Åkerman, MD, PhDDr. Christina Rångemark Åkerman is President of ICHOM, Senior Institute Associate at the Institute for Strategy and Competitiveness at Harvard Business School and Senior Advisor to The Boston Consulting Group. Between 2008 and 2014, she served as Director General for

the Medical Products Agency in Sweden, a national agency employing approximately 750 people and under the aegis of the Swedish Ministry of Health and Social Affairs. During this period, she was also a Member of the Board of the European Medicines Agency, which is responsible for the scientific evaluation of medicines for use in the European Union.

Before her position with MPA, Christina served as Vice President Medical of AstraZeneca Sweden as well as Marketing Company President of AstraZeneca Philippines. Christina received her medical degree from the University of Linköping. She wrote her doctoral thesis in Clinical Physiology and is a specialist in Clinical Pharmacology. She has an Executive MBA in General Management from the Stockholm School of Economics.

Thomas W. Feeley, MDDr. Tomas Feeley is a Senior Fellow at the Harvard Business School’s Institute for Strategy and Competitiveness and the Helen Shafer Fly Distinguished Professor of Anesthesiology at the University of Texas MD Anderson Cancer Center. At Harvard Business School, he works with Professors Michael Porter

and Robert Kaplan on their value-based health care agenda, with an emphasis on the role of information technology. He is also the Head of the Institute for Cancer Care Innovation at MD Anderson, where his work focuses on demonstrating and improving the value of cancer care. Dr. Feeley recently served on the Institute of Medicine’s Committee on Improving the Quality of Cancer Care, which in 2013 released the report Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis.

Dr. Feeley received both his undergraduate and medical degrees from Boston University and trained in anesthesiology and critical care at Boston’s Beth Israel Hospital. He was a faculty member at Stanford University for 19 years, practicing cardiovascular anesthesia and critical care.

Stefan Larsson, MD, PhDDr Stefan Larsson is a co-founding member of ICHOM and global leader of The Boston Consulting Group’s health care payers and providers sector. His research focuses on the topic of value-based health care—how transparency within health care outcomes and patient group costs will drive the transformation of health

care systems. He presented the topic of value-based health care during his TED talk “What Doctors Can Learn from Each Other” as part of a series of talks curated by TED and BCG.

Since joining BCG in 1996, Stefan has worked extensively for clients across the health care industry on issues of strategy, organizational redesign, operational effectiveness, R&D effectiveness, regulatory issues, drug safety, manufacturing, in-licensing strategy, and commercial compliance. Prior to joining BCG, Stefan was an associate professor at the Karolinska Institute. He earned his medical degree from MD, Uppsala and Karolinska Institutet, and his doctorate from Karolinska Institutet and Harvard Medical School.

David Lansky, PhDDavid Lansky, PhD, is the president and Chief Executive Officer of the Pacific Business Group on Health (PBGH) – directing efforts to improve the affordability and availability of high-quality health care. Since 2008, he has led the coalition of 60 large employers and health care purchasers representing more

than 6 million Americans, including Wells Fargo, Intel, Safeway, Walmart, Boeing, CalPERS, and the state of Washington Health Care Authority.

A nationally-recognized expert in accountability, quality measurement and health IT, Lansky has served as a board member or advisor to numerous health care programs, including the National Quality Forum, the federal Health IT Policy Committee, the Catalyst for Payment Reform, the Joint Commission, the National Patient Safety Foundation, the Leapfrog Group, and the Medicare Beneficiary Education Advisory Panel.

Lansky currently is the vice chair of the Health Care Transformation Task Force. He also serves on the Guiding Committee of the HHS Learning and Action Network, the Congressional Budget Office Health Advisors Panel, and the Board of the Alliance for Health Reform.

From 2004 to 2008, Lansky was senior director of the Health Program at the Markle Foundation (NY), and from 1995 to 2004, he established the Foundation for Accountability (FACCT), a public-private venture developing quality measures and web-based tools to help consumers and purchasers assess the value of health care services and providers.

Lansky was a senior policy analyst for the Jackson Hole Group during the national health care reform debate of 1993-94. He led the Center for Outcomes Research and Education at Oregon-based Providence Health System from 1988 to 1993.

He is the author of more than 30 peer-reviewed papers on outcomes research and quality measurement and holds a PhD from the University of California, Berkeley.

Keynote speakers